Stay updated on CaboNivoIpi in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the CaboNivoIpi in Thyroid Cancer Clinical Trial page.

Latest updates to the CaboNivoIpi in Thyroid Cancer Clinical Trial page
- Check2 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study page currently displays a 403 Forbidden error, indicating the study record is inaccessible; the content area has been replaced with a standard error page while site chrome remains, preventing access to the study details.SummaryDifference22%

- Check30 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, signaling a new build of the Study Details page. This likely includes minor content or formatting updates but does not change the study data or eligibility criteria.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a new version of the study details page. This change typically reflects minor content or formatting adjustments rather than substantive updates to the study data.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision label on the page was updated to v3.6.5, replacing the previous v3.6.4. This indicates a recent update to the study record page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe list of participating study locations was updated to include UPMC Hillman Cancer Center and remove the University of Pittsburgh Cancer Institute, reflecting changes in where the CaboNivoIpi trial can enroll patients.SummaryDifference0.1%

Stay in the know with updates to CaboNivoIpi in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaboNivoIpi in Thyroid Cancer Clinical Trial page.